ClinicalTrials.gg
RecruitingNCT06486233Updated Jul 3, 2024

Studying the Effectiveness of Early Invasive Treatment in Elderly Patients With High-risk Non-ST-segment Elevation Acute Coronary Syndrome.

An observational study in Myocardial Infarction, sponsored by Gia Dinh People Hospital. Recruiting at 1 site in Vietnam. Open to participants aged 60 Years and older. Per ClinicalTrials.gov, last updated 2024-07-03.

Sponsored by Gia Dinh People Hospital · Observational

From the registry’s dates

  • Primary completion was expected by Mar 2026, 7 months ago, but the record still lists the study as recruiting.
  • Started Feb 2024; still recruiting 2 years 8 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
385
Ages
60 Years and older
Sex
All
01

Study summary

The goal of this is observational study is to compare about MACE events and predisposing factors related to MACE events in elderly patients with high-risk non-ST acute coronary syndromes receiving early versus late invasive treatment . This study will anwser two questions.

Question 1: What will factors associate with implementing a late invasive strategy in elderly patients with high-risk non-ST-segment elevation acute coronary syndrome ? Question 2: Is a meaningful difference about mortality and complication rates as re-myocardial infarction, heart failure, re-hospitalization, stroke after 12 months between two groups of patients undergoing early invasive and late invasive strategies in elderly patients with in high-risk non-ST-segment elevation acute coronary syndrome?

02

Conditions studied

  • Myocardial Infarction

Keywords

  • percutaneous coronary intervention, elderly, non-ST-segment Elevation
03

In context

Myocardial Infarction

2,779 studies on the registry are indexed under Myocardial Infarction; 417 are open to participants now.

This study's planned enrollment of 385 is below the median of 500 across 999 observational studies indexed under Myocardial Infarction.

Browse Myocardial Infarction studies →

Lead sponsor

Gia Dinh People Hospital is the lead sponsor of 13 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
60 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

All patients aged 60 years and older were diagnosed with non-ST elevation acute coronary syndrome. Diagnosed with high-risk acute non-ST elevation syndrome and treated at Gia Dinh People's Hospital, Thong Nhat Hospital during the study period.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • aged 60 years and older
  • high - risk non-ST-segment elevation acute coronary syndrome (according to the 2023 European Heart Association recommended standards).
  • receives reperfusion intervention.

Exclusion criteria

Exclusion Criteria:

  • Acute coronary syndrome due to stent thrombosis, or coronary artery bypass graft occlusion.
  • Incomplete medical records.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
385 participants (estimated)
Patient registry
No

Groups and cohorts

  • Observe the patient with early percutaneous coronary intervention

    Elderly patients with non-ST-segment elevation acute coronary syndrome receive early percutaneous coronary intervention (\< 24 hours after diagnosis).

  • Observe the patient with late percutaneous coronary intervention

    Elderly patients with non-ST elevation acute coronary syndrome undergoing late percutaneous coronary intervention (≥ 24 hours after diagnosis)

06

What researchers measure

Primary outcomes

  1. In-hospital death

    recorded when death occurs during treatment or is confirmed by in-hospital monitoring

    Time frame: one month

Secondary outcomes

  1. after 12 months death

    determined by the patient follow-up period from hospital discharge until results were recorded

    Time frame: one year

  2. MACE after 12 months include re-admission, recurrent myocardial infarction , stroke, heart failure

    recorded

    Time frame: one year

07

Study locations

1 of 1 sites recruiting
  • Gia Dinh people hospital
    Ho Chi Minh City, Vietnam
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Feb 2024 (actual). Primary completion is estimated for Mar 2026, 24 months after the start.

Of 377 non-industry observational studies under Myocardial Infarction, half reached primary completion within 49 months of starting (the median), counting those still running; a quarter within 20 and three quarters within 132. This study's planned 24 months is below that.

Counting every sponsor, half of 418 studies reached it within 41 months; a quarter within 18 and three quarters within 113.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 12, 2024
First posted
Jul 3, 2024
StartActual
Feb 22, 2024
Primary completionEst.
Mar 1, 2026
CompletionEst.
Mar 1, 2028
Last update
Jul 3, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 3, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06486233
Lead sponsor
Gia Dinh People Hospital
Responsible party
Sponsor
First posted
Jul 3, 2024
Start date
Feb 22, 2024
Primary completion
Mar 1, 2026 (estimated)
Completion
Mar 1, 2028 (estimated)
Last update
Jul 3, 2024

Study contacts

Sang Thanh Nguyen, Doctor
Contact
drsangthanhnguyen@gmail.com
+84902489252

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion